Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • Graphically speaking, the timing seems perfect for purchasing the stock close to the USD 66.8 support.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.53 for the 2017 fiscal year.
  • With a P/E ratio at 14.27 for the current year and 12.59 for next year, earnings multiples are highly attractive compared with competitors.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The technical configuration over the long term remains negative on the weekly chart below the resistance level at 75.35 USD
Ratings chart
Sector Drug Retailers - NEC
1st jan.Capitalisation (M$)Investor Rating
CVS HEALTH-9.24%71 720
WALGREENS BOOTS ALLIANCE-13.34%69 681
EXPRESS SCRIPTS HOLDING CO0.33%39 091
MCKESSON CORPORATION10.51%32 772
AMERISOURCEBERGEN CORP.13.16%19 477
CARDINAL HEALTH INC-15.84%19 023
JOINTOWN PHARMACEUTICAL GRO..-6.99%5 485
MEDIPAL HOLDINGS CORP19.52%4 801
WELCIA HOLDINGS CO LTD40.34%4 678
MATSUMOTOKIYOSHI HOLDINGS C..58.51%4 444
SUZUKEN CO., LTD.20.29%4 230
JEAN COUTU GROUP PJC INC16.55%3 515
CHINA NATIONAL ACCORD MEDIC..--.--%3 445
CLICKS GROUP LTD48.95%3 205
REALCAN PHARMACEUTICAL CO L..--.--%3 118
CHINA NATIONAL MEDICINES CO..-14.42%2 990
More Results
Financials ($)
Sales 2017 184 B
EBIT 2017 9 955 M
Net income 2017 5 255 M
Debt 2017 24 517 M
Yield 2017 2,81%
P/E ratio 2017 14,11
P/E ratio 2018 12,39
EV / Sales 2017 0,52x
EV / Sales 2018 0,49x
Capitalization 71 720 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart CVS HEALTH
Duration : Period : Day
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Duration : Period : Week
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders